Tong-Meng Yan

Title: Innovations of Tong-Meng Yan in Cancer Treatment

Introduction

Tong-Meng Yan is a notable inventor based in Macau, China. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the development of nucleic acid molecules that can be utilized in therapeutic applications.

Latest Patents

Tong-Meng Yan holds a patent for "Nucleic acid molecules and uses thereof." This patent describes a method of treating subjects suffering from cancer by administering an effective amount of double-stranded RNA molecules. The RNA molecules are isolated or derived from bacteria of the genus. The patent also outlines a method for inhibiting the growth or proliferation of cancer cells by contacting them with the RNA molecule. Additionally, it includes a pharmaceutical composition for treating cancer that comprises the RNA molecule and a pharmaceutically tolerable excipient, as well as a double-stranded RNA molecule and a recombinant vector containing the double-stranded RNA molecule.

Career Highlights

Tong-Meng Yan is affiliated with the Macau University of Science and Technology, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on cancer therapies.

Collaborations

Some of his notable coworkers include Zhi-Hong Jiang and Kai-Yue Cao, who contribute to the collaborative research efforts in the field of cancer treatment.

Conclusion

Tong-Meng Yan's innovative work in developing nucleic acid molecules for cancer treatment showcases his commitment to advancing medical science. His contributions have the potential to significantly improve therapeutic options for cancer patients.